This is a technical conference exclusively designed to help the professionals of the Pharma Industry to take critical decisions around controlling genotoxic impurities in drug development process. This is a two-day conference, divided into separate streams which will provide clarity on identification, analysis and regulatory specifications around genotoxic impurities.

The 4th edition of CPhI’s Annual Biosimilars will focus around the critical aspects of Process Development and Analytics. This conference has been carefully designed to discuss strategies for developing the first commercially successful molecule. Also introducing Commercialisation of Biosimilars Seminar – An exclusive one day seminar on commercialisation strategies for biosimilars in developed as well as emerging markets.

CPhI’s seminar on Biodegradable Polymers is specifically made to discuss problems around advance therapeutic application, techniques like coacervation and technologies like double emulsification and multiple emulsification for biodegradable implants, scale-up challenges and how to overcome them. Harald Liedtke, Technical Marketing Director, Biomaterials, Evonik Industries AG, Germany and Kevin Burton, Senior Director, R&D, Evonik Degussa Corporation, USA will discuss the most critical issues of microsphere development, scale-up challenges, hot melt extrusion and more.

The 2nd Annual Global Pharma Regulatory Summit 2013 brings a complete regulatory week focusing on the regulations for US, Europe and ROW markets & regulations for API, QbD, GDUFA, eCTD and many more growing concerns. The programme is enhcanced with interactive workshops on newly evolved GDUFA guidelines and practical study on eCTD lifecycle management.

A high-level strategic conference made to overcome challenges around crystallization and optimum utilisation of resources. Crystallization 2013 will focus on opportunities for further growth in developing high quality APIs.

After the success of Pharma IPR India 2012, CPhI India is glad to announce the 2nd Annual Pharma IPR India 2013, where patent regimes and market entry strategies will be discussed of over 10 countries including: USA, Europe, Japan, China, Korea, South Africa, Brazil, Mexico, Russia and South East Asia (Malaysia, Singapore, Thailand). This unique conference will address all critical intellectual property related queries in the pharma and biopharma sectors and provide on-the-spot solutions from leading global industry experts.

It will be held on 14th -15th March 2013 at Shanghai, industry and thought leaders will gather together to discuss new trends and innovation in the use of biomaterials in medical devices. From concept to market, biomaterials advances are increasing driving the industry; join us to learn all the latest.

Organized by CPhI Conferences, it will be held on May 23rd - 24th , 2013 in Shanghai, China, aiming to provide most valued and high-quality platform for all the industry stakeholders. Around 150 senior decision makers from relevant government organs/ industry associations, domestic and oversea top pharmaceutical manufacturers, Pharmaceutical distributors, temp-sensitive medical device companies, 3PL/4PL, cold chain technology/device suppliers (in packaging, refrigeration or temp-control, etc), software/ IT system providers, and etc, will gather together in Shanghai sharing ideas and experience. The heat topics, such as regulatory practices, industrial integration & cold chain process intensification, quality assurance upgrading and technology innovation will be put on the table for delegates to discussing the best practical model, exploring the right future direction, and discovering more business opportunities as well.

Co-organized by CCCMHPIE and UBM Conferences, it will be held on June 25th - 26th in Shanghai, China. As the supporting activity of CPhI China, the objective of the one and a half day forum is to provide communication and display platform for professionals in medical area, collecting the newest market information and provide various networking opportunities to discuss and showcase evolving pharmaceutical regulatory, market and technology under the support of globally vibrant speaker team line up from government and leading pharmaceutical companies. The forum is divided into three modules, Module A: International Regulatory Environment and Its Effect for Drug Exporting; Module B: Risk Management and On-Site Inspection; C: WHO Prequalification and International Procurement.

Start new, Strive to be Elite, inscribed by Dr. Kerong DAI, Academician from Chinese Academy of Engineering, Implantable and Interventional Medical Devices China Conference (IIMD China) ended with great success on 20th July in Shanghai. This conference has brought together the forefront of this industry, speakers from Food and Drug Administration, Shanghai Food and Drug Administration, Shanghai Ninth People’s Hospital, Nanjing General Hospital of Military Command PLA, Medtronic, Microport and Smith&Nephew and other business organizations get-together, discussing and sharing the latest technical results and policies and regulations. More than 100 delegates got involved. After the successful hosting of IIMD Conference in 2011, the 1st IIMD China (Shanghai) & the 2nd IIMD China (Beijing) , 3rd IIMD China 2013 will be held this 23rd -24th May in Shanghai, which is another must-attend event.

It will bring about 120+ key decision-makers from government agencies, generic and bio-pharma manufacturers in gathering for deeper discussing about the concerns and bottlenecks during the process of generics drug R&D, application, registration and production. Interactive topics will be diversified from the 3 perspectives: regulatory updates; process quality innovation and "Going-out & Introducing-in" R&D cooperation. This is an indispensable industry insights networking platform tailor-made for domestic & overseas generic-pharma professionals, which contribute a lot to the generic drug value-chain growth and know-how upgrading.

It will be held in Shanghai, China on 17th - 18th April, 2013. This conference is organized by CPhI Conferences and has brought together top-level industry executives from government & regulatory agencies (FDA, NIFDC), international pharma companies (Pfizer, Huahai, Haisun, Hengrui, NNE, Frontage, Sanovel), QbD/PAT companies (Malvern) etc. to discuss industry hot issues and provide communication platform for professionals who engaged in drug R&D and quality control.

CPhI introduces for the first time a conference designed for project managers in the pharma industry to help them ensure flawless implementation of project management, to actively monitor and control project activities within the defined cost, quality and time and to meet the increasing export demand.

The 3rd Annual PharmaLytica will help to learn best practice strategies around regulatory compliance, analytical method development and transfer, PAT, formulation analytical development, particle size characterisation and rapid microbiological techniques.

Pharma Sales Force Effectiveness and Automation conference will focus on the latest training modules to reduce attrition, best practice strategies for effective segmentation and targeting to maximise sales output, strategies for setting the right KPI’s to make the sales team responsible, robust CRM practices and latest techniques in analytics and reporting.